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Contraception and Abortion, 
Foes or Friends? 
by 
The Rev. Mons. Jacques Suaudeau 
The author, who is both a medical doctor and a priest, serves as an 
official for the Pontifical Council jor the Family, in the Vatican. 
Thirty-two years ago, July 26, 1968, in the midst of the "sexual liberation" 
wave, Pope Paul VI gave his famous encyclical Humanae Vitae, in which 
he condemned with clarity and firmness the use of any contraceptive 
technique for "family planning" purposes. 
All these years later, the time has come to make a judgment on the 
insight of this encyclical , with a better knowledge of the physical and moral 
consequences of the contraceptive pill. 
The promoters of contraception opposed the moral judgment of Pope 
Paul VI. They presented the so-called "pill" as an antiovulatory agent, 
respectful of human life, with nothing intrinsically wrong attached to its 
action. And they insisted on the fact that the pill was " the most effective 
remedy against abortion" (Evangelium Vitae nO 13), and, as such, a true gift 
to humanity. 
In the following report we would like to answer these two questions, 
in the light of present knowledge : 
• Are oral contraceptives respectful of human life? 
• Is contraception the true way of preventing abortion? 
We will deal here only with oral contraception I , either as combined 
estrogen-progestogen preparation - the so-called "contraceptive pill" - or 
as low-dose, progestogen-only preparation, the so-called "mini-pill." 
We will not consider in thi s study the other methods of modem 
contraception - "postcoital contraception", long-lasting intramuscular 
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injectable progestogen, implants, and intrauterine devices, because they are 
clearly abortive in their action and outside of the eth ics ofcontraception.2 
I. The Abortivity of Oral Contraceptives 
Oral contraceptives have been presented as purely antiovulatory 
agents, and all the discussion which preceded and immediately followed 
the publication of the encyclical Humanae Vitae took this affirmation for 
granted. However as early as the 1950s3 it was already clear that the 
mechanism of the highly effective compound estrogen-progestogen could 
not be limited to a pure prevention of ovulation . Today, for the combined 
oral contraceptive and, even more, for the progestogen-only pill, an 
abortifacient action has been demonstrated which does change the ethical 
perspective about these contraceptives. 
A. The Estrogen-Progestogen PiII4 
It is known today that the infertility which results from the action of 
combined oral contraceptives is caused by the intervention of these 
compounds on least at three levels : 
• on the hypothalamic-pituitary-ovarian axis 
• on the cervical mucus 
• on the uterine endometrium 
1) Ovarian function is generally suppressed, but some "escape ovulations" 
do happen with combined oral contraceptives. 
The inhibition of ovulation by estrogen-progestogen compounds is 
strong.5 The first contraceptive pills which were delivered to the market in 
the 60s contained high concentrations of estrogens and progestogens and 
certainly acted by blocking ovulation . The initial formulation of the 
combined oral contraceptives was of 0.150 mg. mestranol , 9.85 mg. 
norethynodrel. Mestranol was then replaced by the more potent Ethinyl 
Estradiol, which made it possible to reduce the dose of estrogen in the pill. 
Because of the incidence of side effects and complications, especially 
thromboembolism, associated with the use of these early contraceptive 
pills, respective concentrations of estrogens and progestogens in the 
contraceptive pill subsequently have been reduced. The first important 
change occurred in the late 1960s when there was a massive shift from 
higher dose pills to the "classic" pill , containing on ly 50flg. of estrogen (as 
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ethinyl estradiol) and a lower dose of progestogen (1 mg. of a 19 
nortestosterone derivative, as an example, norethisterone acetate). 
These preparations were themselves superseded in the mid-1970s by 
" low-dose pills", containing only 30-40 ).lg. estrogen and I mg. or less 
progestogen. Finally, in the 1980s, phasic and 20 ).lg. ethinyl estradiol 
preparations were introduced. 
A more relative inhibition of the pituitary gonadotropic function6 has 
resulted from this lowering of the doses of active ingredients in the 
contraceptive pill, allowing more elevated plasmatic concentrations of FSH 
(Follicle Stimulating Hormone) and of LH (Luteinizing Hormone)7, and 
therefore a less effective suppression of ovarian activity.8 Indeed, 
plasmatic concentrations of estradiol and progesterone remain low when 
oral contraception is sought after with these new low-dose compounds.9 
These formulations , which contain less of the steroids 10, as well as the 
triphasic compositions, do inhibit effectively the pituitary-ovarian 
function . I I However, the effectiveness of their antiovulatory action can be 
incomplete in those persons who are more resistant to this inhibition. 12 
Taking certain medications jointly with oral contraceptives (especially 
psychotropic drugs and antibiotics), and the occurrence of gastrointestinal 
disturbances (gastroenteritis, diarrhea), can also lessen the ovarian 
suppression activity of the oral contraceptives. 13 
Even in these studies where relatively important doses of ethinyl 
estradiol (50 ).lg.) are used, the LH urinary elimination remains within the 
limits of normality, and in some women (in one cycle out of five), the study 
of plasmatic estradiol concentrations shows that ovarian follicles do 
develop despite the use of the contraceptive pill (Elstein et coil. , 1974)14 
Ultrasonographic scanning of the ovaries confirm that, in 30 to 50% of the 
treatment cycles, ovarian follicle-like structures do develop to a diameter of 
10 mm or greater, before gradually diminishing in size.15 When women 
were monitored by daily pelvic ultrasonography along the whole cycle, it 
has been found that, in at least 5% of the cycles, a rupture of the follicle 
wall occurred and ovulation was then detected. 16 Hormonal assessment in 
blood confirmed the reality of these ovulations. 
Thus, with the pills offered today on the market, ovulations are indeed 
verified despite contraception, at the rate of one for ten or twelve cycles. 17 
Such "escape ovulations" can be followed by fertilization , if there is sexual 
intercourse within the five days following the ovulation . 
2) Combined oral contraceptives thicken cervical mucus 
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It is probable that part of the contraceptive effect of the estrogens-
progestogens compounds is due to their action on the uterine cervix. They 
transform cervical mucus into the progestogenic type, thick and scanty, 
with impaired spin-barkeit and poor or no ferning pattern . IS This makes it 
more difficult for the spermatoza to penetrate across the cervix. 19 
3) Combined oral contraceptives impair endometrial receptivity 
The third way in which combined oral contraceptives may achieve 
female sterility is by maintaining the uterine endometrium in an atrophic 
state, non-receptive to the implantation of a possible embryo. Here, it is the 
gestogen part of the contraceptive which is responsible. It provokes a 
morphological dystrophy of the uterine mucous membrane?O 
Histological stud/I of endometrial biopsies from women taking 
combined oral contraceptives shows that from cycle day 5 through 24 the 
proliferation of endometrial glands is suppressed. At first the stroma 
appears dense and fibrous , then it becomes edematous, and eventually it 
may undergo pseudodecidual changes. Arterioles are poorly developed or 
absent from large areas of the endometrium; venules, however, may 
sometimes be dilated to large sinuses; in contrast to the suppression of 
glandular proliferation, the secretory activity is accelerated at the 
beginning. However, it decreases from mid-cycle on and the glands then 
remain narrow and straight. The secretory activity of the endometrium 
never develops to the extent characteristic of the late secretory phase of a 
menstrual cycle. 
Examined under scanning and transmission electron microscopy, 
endometrial surface appears altered, with fewer ciliated cells and 
incomplete secretory modifications. 22 Endosonographic assessment23 
shows that, in women taking low-dose combined oral contraceptives, the 
endometrial thickness is lower than 8 mm for all cycles, showing a 
pronounced effect of the oral contraceptives on the endometrium, which 
impairs endometrial receptivity. 
The study in endometrial tissue specimens of the expression of these 
integrins which are closely associated with endometrial receptivity 
(Somkuti et aI. , 1996l 4, shows that in the endometrium of combined oral 
contraceptive users, there are significant alterations in cycle-dependent 
integrin expression (a 1(31 , a4(31 and av(33) with a specifically increased 
glandular a4(31 and decreased av(33 expression . This altered expression of 
the integrins corresponds to an unreceptive endometrium and predisposes 
to implantation failure or early pregnancy loss. These alterations thus 
provide evidence that the morphological changes observed in the 
endometrium of women taking combined oral contraceptives have 
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functional significance and that reduced endometrial recepttvlty does 
indeed contribute to the contraceptive effect of the oral contraceptives. 
4) The abortive effect of combined oral contraceptives 
From this study, we can conclude that the present combined oral 
contraceptives do allow on one hand some development of ovarian follicles 
with possible ovulation and subsequent fertilization , and, on the other hand, 
makes impossible the nidation of the product of this fertilization. 
Therefore, they do have an abortifacient effect. 
We lack a reliable and easy to use method to detect a living embryo 
before its implantation. Therefore, it is not possible to have a precise idea 
of how many early abortions can be brought on by the use of combined oral 
contraceptives. We can only make a guess from the difference calculated 
between the total number of poss ible escape ovulations and the number of 
actual pregnancies observed in women taking oral contraceptives. 
If we assume that escape ovulations do happen in 5% of the cycles 
while taking combined oral contraceptives, and if we estimate that 
fertilization can follow in 25% of these cases we would have a possibility 
of 1.25 fertilizations for 100 cycles. That is around ten fertilizations for 
100 women per year. Taking into account the Pearl index for combined 
oral contraceptives which is around 1/ 5 we would have for each one 
embryo able to implant and develop despite contraception, nine embryos 
eliminated early due to reduced endometrial receptivity. This means that a 
woman taking low-dose combined oral contraceptives for 15 years would 
lose approximately 1.3 embryos in this way. 26 
B. Progestogen-Only Pills (The Mini-Pill) 
The situation is quite different with the low-dose progestogen-only 
pills. These have been developed in recent years as an alternative to 
combined oral contraceptives. Called ·'mini-pills,,27 because of their 
reduced steroid content28, these compounds are particularly well-suited to 
women with contraindications to the estrogen in combined oral 
contraceptives, for women who experience side effects with the combined 
pill , for breastfeeding mothers, and for older women. 
I) Progestogen-only pills do not suppress ovarian activity 
Different from combined oral contraceptives, progestogen-only pills 
do not have a significant action on the hypothalamic-pituitary-ovarian 
axis. 29 They suppress ovulation in less than 50% of the contraceptive 
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cycles.30 Most of the cycles during low-dose pregestogen administration 
are probably ovulatory, as suggested by endometrial morphology and 
clinical determinations.31 As a result, an important follicular activity32, 
inversely proportional to the amount of administered progestogen33, can be 
evidenced in women taking this kind of oral contraceptives. 
2) Progestogen-only pills thicken cervical mucus 
Under the effect of progestogen-only oral contraceptives, cervical 
mucus is highly viscous, scanty, opaque, and cellular34, gestagenic-type. 35 
The meshwork which constitutes the infrastructure of the cervical secretion 
appears greatly tightened, giving the typical appearance of cervical mucus 
in the late luteal phase.36 On penetration tests, sperm cells remain on the 
surface of the mucus or are trapped in the superficial layers of the woof. 
Sperm penetration comes to a stop 3-4 cm from the sperm-mucus contact 
point. 37 In vivo post-coital sperm penetration tests in women taking the 
mini-pill show that, in 70-80 percent of the time, there is little or no 
penetration . 38 A direct, sperm agglutinating effect of the progestogens in 
vitro has also been reported . 39 However, some spermatozoa do pass 
through the barrier of cervical mucus despite the tightening of its 
meshwork.40 Indeed, there is a relatively high incidence of ectopic 
gestations in patients using progestogen-only oral contraception. 41 The 
risk of ectopic pregnancy among women using this form of contraception 
may be increased from two to five-fold when compared with women of 
childbearing age.42 
3) Possible action on Fallopian tubes 
A possible explanation of the high incidence of ectopic pregnancy in 
mini-pill users is altered tubal motility. In vitro studies have shown that 
19-norsteroids diminish the intensity and frequency of peristaltic tubal 
movements.43 On the other hand, a decrease of ciliation has also been 
observed in the infundibular and ampullar regions of the oviduct, with 
microvilli scarce and of irregular height in women given steroidal 
contraceptive treatment.4~ But other investigators did not find any 
abnormality upon histological examination of tubal epithelium in mini-pill 
users.45 Progestins could also reduce the intensity and frequency of cilia 
action, thus slowing the rate of ovum transport (McCann, 1994).46 On the 
whole, there is no clear-cut evidence concerning these supposed effects. 
4) Progestogen-only pills oppose the implantation of early embryos in the 
endometrium 
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It is the endometrium which is the main site of action of low-dose oral 
progestagens. Progestagens interfere with the normal , cyclic development 
of the endometrium47, and in that way prevent the implantation of early 
embryos. Animal studies have shown that progestogen makes implantation 
impossible in 84% of all cases, which prevents pregnancies at a 100% 
rate .48 
The endometrium of women taking low-dose, progestogen-only oral 
contraceptives presents, during the first part of the contraceptive cycle, a 
proliferative aspect, with varying degrees of mitotic activity.49 Early 
secretory activity reaches a maximum on days 13 to 15, but never 
progresses to a full development. This abortive, secretory phase is 
followed by a regression of the glands. 5o Suppression is total, during the 
whole cycle, with glandular atrophy, compact stroma, fibrosis , moderate 
decidual reaction, for women taking 300 J.lg norethindrone or 30 J.lg 
norgestrel per day.51 Electron microscopy shows that the endometrium in 
development during the first part of the cycle presents an irregular 
secretory pattern, with presecretory changes observed in some cells in each 
gland while the remainder of the cell components retains proliferative 
features. Such an irregular cell maturation is not compatible with a normal 
implantation.52 
In agreement with this morphologic " suppression" of the 
endometrium, studies of the action of oral progestogen-only contraceptives 
on the uterine biochemistry of rats have shown53 have shown a general 
depression of the metabolic status of the uterus . There is a diminution in 
energy production in the uterus under the influence of the progestogen. 
Therefore, low dose oral progestogens interfere with the cyclic 
development of the endometrium, allowing either an irregular cellular 
maturation, or suppressing it. Under the mini-pill , the energetically 
deprived uterus during conception would be in a " sleepy state" , unprepared 
for the implantation of an embryo. 
5) The abortive action of the " mini-pill." 
Oral progestogen-only contraceptives neither suppress ovulation 
consistently nor prevent totally the passage of spermatozoa through the 
uterine cervix. So, it must be their suppressive action on the endometrium 
which prevents development of a pregnancy. The mini-pill allows probable 
fertilization in a large number of cases, but does not permit development of 
an embryo - at least in the uterus - because it hinders its implantation. 
Therefore this is not a contraceptive action but an abortifacient one. 
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If we assume that ovulation can occur in 37% of the contraceptive 
cycles of women taking the mini-pill , with fertilization following in 25% of 
these cases, then nine fertilization s could occur per 100 cycles. That is to 
say, 75 fertilizations occur per 100 women per year, in women taking the 
mini-pill. Given that the Pearl index for the mini-pill varies between 1.5 
and 6, with a mean value 54 of 3.75 (3 .1 for the 25-29 age group), 55 there 
could be, for each 3.75 embryos able to implant and develop, 71 embryos 
eliminated early per 100 women per year. Thus, a woman taking the mini-
pill continuously would have about 10 early abortions during 15 years of 
sexually active life. 56 However, given that the mini-pill is taken by less 
than 10% of contraceptive users, the total amount of these abortions is 
much smaller than the number of abortions caused by combined oral 
contraceptives. 
C. Discussion 
Oral contraceptives, therefore, provoke early abortions, more than one 
in her active sexual life for the woman taking the combined pill , and up to 
ten abortions for the woman taking the mini-pill. This cannot be 
overlooked. 
I) Is the number of abortions caused by oral contraceptives too small to be 
considered a problem? 
One could answer that the number of abortions related to the use of 
oral contraceptives is relatively small when compared to the number of 
spontaneous abortions which occur after fertilization and before 
implantation, because of genetic defects, immunological incompatibilities, 
or grave malformation. 57 But the fact that there may be spontaneous 
abortions does not justify abortions caused by contraceptives, any more 
than the daily occurrence of human death by car accidents could justify 
homicide through planned auto collisions. 
On the other · hand, if we relate the abortions induced by oral 
contraceptives to the total number of women using such medications, we 
arrive at some impressive figures . B. Bayle estimates, for example, that 
between 120,000 to 400,000 embryos a year are aborted this way in France. 
This is almost as many as there are induced abortions in that country.56 
2) Are these abortions not to be considered as such because they concern 
only pro-embryos? 
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A second argument for not considering problematic those abortions 
induced by oral contraceptives is to declare that they are not true embryos. 
Different investigators, such as A. McLaren59 and also theologians, such as 
Rev. Norman Ford of Melburne, Australia60 maintain indeed that, before 
the 15th day following fertilization, or at least before its implantation in the 
uterus (which starts approximately on day 5 after fertilization , the early 
embryo cannot be considered as a true individual because its blastomeres 
are totipotent and can multiply to form other embryos once detached, as 
occurs naturally with monozygotic twins.61 
But the fact that a totipotent cell can divide into two individual beings 
does not contradict the continuity in the development of the embryo.61 We 
do not have in the early embryo an indeterminate system which could 
originate, by division, two determinate systems. There is, instead, a first 
being from which can arise, through accidental detachment of one cell, 
another being with its own genetic program. 
Some may also say, on theological grounds, that the embryos 
eliminated by oral contraceptives do not have the same value as true human 
beings because they have not yet been informed by a rational , human 
soul.63 Not only is this thesis philosophically incorrect64 , but it also lacks 
any biological grounding. It has been indirectly disapproved by the Church 
in repeated condemnations of induced abortions (Declaration on Procured 
Abortion, Congregation for the Doctrine of the Faith, November 25 , 1974; 
"extending from conception to birth," Evangelium Vitae 58). 
II. Oral Contraception and the Practice of Abortion 
After recognizing the abortive effect of oral contraceptives, one can 
ask if the connection is limited to pharmacology and early embryology, or 
if it goes further. 
Rich from many points of view, the recent encyclical of Pope John 
Paul II, Evangelium Vitae, has brought a new dimension to the discussion 
of contraception started by Humanae Vitae . In commenting on the "anti-
life" aspects of contraception, the Pope declares: 
Certainly, from the moral point of view, contraception and abortion 
are specifically different evils: the former contradicts the full truth of 
the sexual acts as the proper expression of conjugal love, while the 
latter destroys the life of a human being; the former is opposed to the 
virtue of chastity in marriage, the latter is opposed to the virtue of 
justice and directly violates the divine commandment "You shall not 
kill." But despite their differences of nature and moral gravity, 
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contraception and abortion are often closely connected, as fruits of the 
same tree ... (E.V. 13) 
Thus, in this very important passage, John Paul" denounces not simply the 
abortivity of the contraceptive pill , but the mere existence of a connection 
which would exist between contraception and abortion. 
A. The Assertion: "Contraception is the most effective remedy against 
abortion. " 
1) The position of the promoters of contraception. 
This statement of John Paul " is all the more surprising because, 
although it is the first time that such an accusation appears in an official 
Church document, it directly opposes the basic argument of all the 
promoters of " Family Planning", from the earliest days of the I.P.P.F. to the 
more recent publications of the FNUAP or of the WHO on this question. 
This argument lies in the quasi axiomatic affirmation that "contraception, if 
made safe and available to all , is the most effective remedy against 
abortion ."(E.V.13). 
Following this argument, oral contraceptives would represent indeed a 
"lesser evil" compared to the greater evil of voluntary abortion. The 
promotion of oral contraception, because it would lead to a decrease in the 
number of voluntary abortions, and particularly the unsafe ones, would be 
therefore more than justified. On the contrary, opposition to contraception, 
for religious or cultural reasons, would not do any good, because it would 
increase recourse to abortion .65 The Catholic Church has actually been 
accused of indirectly promoting abortion because of its intransigent stand 
against hormonal contraception. John Paul" writes: 
The Catholic Church is .. . accused of actually promoting abortion, 
because she obstinately continues to teach the moral unlawfulness of 
contraception (Evangelium Vitae 13). 
Given this, one wonders why the Pope has judged it necessary to 
disagree publicly with this opinion in the most official document of the 
Church. Neither Humanae Vitae nor any later document of the 
Magisterium has dared to express such disagreement. 
2) The position of Evangelium Vitae 13. 
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If we now analyze this thesis in favor of promotion of contraception, 
we find that in the assertion " Prevention is better than abortion", there is an 
obvious weakness. The opposition between contraception and abortion is 
taken for granted, and no effort is ever made to prove it. But does 
increased contraception really mean decreased induced abortions? The 
Holy Father expresses clear doubts about it, again in the same paragraph of 
Evangelium Vitae: 
When looked at carefully, this objection is clearly unfounded. It may 
be that many people use contraception with a view to excluding the 
subsequent temptation of abortion, but the negative values inherent in 
the "contraceptive mentality" . .. are such that they in fact strengthen this 
temptation when an unwanted life is conceived. (£. V. 13) 
John Paul II supports these doubts by the statement that it is precisely in the 
places where the teaching of the Church on contraception is not welcomed 
that abortion is strong: 
Indeed, the pro-abortion culture is especially strong precisely where the 
Church ' s teaching on contraception is rejected. (£. V. 13) 
Thus, if we follow John Paul II , the practice of contraception, far from 
bringing down the recourse to abortion, could in fact favor it. 
This affirmation of John Paull II is not, in fact, based on mere 
opinion. If in 1968, Pope Paul VI did not have the necessary data to bring 
forth such an argument in Humanae Vitae due to the relative newness of 
contraception then, statistics are now available which deomnstrate the 
accuracy of the Pope's judgement. These statistics, which will only be 
sampled in the present study, show that one passes easily from 
contraception to abortion, that contraceptive users are the main applicants 
for legal abortion. Also, these statistics show that the spread of 
contraception in different countries has not brought about the decrease in 
voluntary abortions which had been expected. 
B. The Practice of Contraception May Lead to Abortion . 
I) Contraceptive users are the main applicants for abortion. 
In a study carried out in Sweden66, on a sample of 2,621 women of 
Gotebord, aged 19 to 24 years, followed from 1981 to 1986, and of whom 
89% were using oral contraception, it was found that 43% of these became 
pregnant during that period, and that 44% of these pregnancies were 
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terminated by a legal abortion. Thus, despite an easy access to 
contraception and its general use, the abortion rate in that group remained 
high. 
In a study done in Finland from 1976 to 1993 ,67 to check the efficacy 
of a promotion campaign for contraceptives among adolescents, the 
investigators did find a decrease in the number of abortions, from 4,143 to 
1,513 . However, the reduction observed in childbirth, from 5,376 to 1,655 , 
was even more important. These adolescents, while using contraception, 
did in fact continue to have recourse to abortion. In all the provinces where 
contraceptives were promoted, at the end of the 1990s, the number of 
abortions did not drop but rose instead, and did not start to diminish before 
the 1990s, in parallel with the drop in the birth rate. Thus, the first effect 
of this promotion of contraceptives was to lead users to adopt a more 
negative attitude toward respect for life of the unwanted child.68 
K. Sidenius and N.K. Rasmussen69 observe that 90% of the 110 
teenagers admitted for an abortion in Herlev Hospital , Copenhagen, 
Denmark, from 1977 to 1978, had previously received information on 
contraception and that 60% of them did use some form of contraception. 
Most of these adolescents had started to have sexual relationships before 
age 15 . All of these abortions were therefore the result of contraception 
failures. 
The Allan Guttmacher Institute (affiliated with the American 
Federation for Family Planning) published a study in 1996, carried out in 
1994-1995 on 10,000 women who requested an abortion. This study shows 
that 57.5% of these women did use a contraceptive method, at least during 
the month before contraception.70 
V.A.H. Pearson et al. 71 , in a study publi shed in 1995 about undesired 
pregnancies among adolescents, reported that 80% of these adolescents 
declared that they were using a contraceptive during the period in which 
they had conceived. These rather surprising results are corroborated by 
E.S. Williams72 who observed a proportion between the use of a 
contraceptive at the time of the first sexual relations and the subsequent 
occurrence of a pregnancy. As this proportion cannot be explained only by 
contraceptive failures , this investigator suggests that the practice of 
contraception may lead, among unmarried young persons, to an increase in 
sexual promiscuity with a multiplication of the number of sexual relations. 
This, in turn, would be responsible for the epidemic of unwanted 
pregnancies. 
2) Spread of modern methods of contraception has not brought the 
expected drop in voluntary abortions. 
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If we look now at the general statistics on abortion throughout the 
different countries, we do not find a decrease in induced abortions since the 
beginning of widespread contraception. More often, we find a plateau or 
even a relative increase in abortions. 
In the United States, for instance,73 the reported number of abortions 
rose continuously, parallel to the spread of contraception, from 988,267 in 
1972 to 1,429,577 in 1980, leveling off between 1980 and 1984. Between 
1993 and 1994, the annual number declined from 22 to 21 per 1,000 
women aged 14-44 years. This small decline is related to the parallel 
decline in child birth. 
In Great Britain74, in 1971 , 95 ,000 legal abortions were recorded per 
783,000 births. That is one abortion for every eight births. In 1986, the 
number of legal abortions grew to 148,000, while there were only 661 ,000 
births. That is one abortion for every four births. Thus, the number of 
voluntary abortions in this country did increase in a noticeable way, 
precisely during the period when oral contraceptives were the most widely 
promoted and used. 
In France, the total number of registered abortions has only slightly 
diminished in the last twenty years, from 250,00 per year in 1976, 
immediately after the legalization of abortion, to 220,000 per year in 
1994.75 Meanwhile, contraception has become part of the life of French 
women, with 70% of them between the age of I 8-49 using a contraceptive 
method. 76 Mrs. Blayo, from the " lnstitut national d ' Etudes 
Demographiques", has declared : "This slowness (in the diminution of 
abortion) alarms those who thought that the spread of medica Ii zed and very 
efficient contraceptive methods could rapidly resolve the problem ... To 
encourage couples to an ever greater mastery of their reproduction 
evidently brings them determination not to accept failures. "n In other 
words, promotion of contraception leads people to more adamantly reject 
the child who dares to present itself despite contraception. 
C. Contraception ~nd abortion are " fruits of the same tree." 
Faced with these results, one has to admit that contraception has 
obviously not helped to d~crease abortion in the way expe~t~d. - This is 
because one passes easily from contraception to abortion. Therefore, there 
must be something in common between them, despite their obvious 
differences. Pope John Paul II puts it this way in Evangelium Vitae: 
The close connection which exists, in mentality, between the practice of 
contraception and that of abortion is becoming increasingly obvious. 
(£VI3) . 
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M. Rhoneimer78 rightly observes that John Paul II does not say that 
abortion is the consequence of an anti-life mentality which would be 
already present in the contraceptive mentality. John Paul II writes instead: 
. .. the negative values inherent in the "contraceptive mentality" - which 
is very different from responsible parenthood ... are such that they in fact 
strengthen this temptation (of abortion) when an unwanted life is 
conceived.(EVI3) 
Thus, for the Pope, contraception comes first , not as a mere by-product of 
an anti-life mentality, but with its own negative specificity of contradicting 
the truth of the sexual act. In the contraceptive mentality, it is not hate for 
the life of a possible child which comes first. In fact, the possible child is 
not even thought about. What comes first is the intention to have sexual 
intercourse with someone of the other sex, with the associated intention to 
prevent this freely decided sexual intercourse from giving origin to a new 
life. Thus, as M. Rhonheimer puts it ,79 the contraceptive mentality plunges 
its roots into a sexual behavior in which one exonerates oneself from one' s 
procreative responsibility. As a consequence, the parents who find 
themselves with the "misfortune" of a conception, fruit of the failure of 
contraception, do not feel truly responsible for this new life. They have 
indeed chosen to not be the cause of a new life by excluding the procreative 
dimension of their sexual acts . In this case, the baby is "truly unwanted." 
Pope John Paul II puts it in Evangelium Vitae: 
.. . abortion becomes the only possible decisive response to failed 
contraception (E VI3). 
In that perspective, it is understandable that a woman could enter into 
the abortion mentality the same way she entered into the contraception 
mentality. She does not, really, want to suppress a human life as such; she 
does not even consider that life to be a real one. What she does want is not 
to assume the responsibility of her sexual behavior. In both the acts of 
contraception and abortion, there is a kind of self-inflicted blindness. The 
woman considers only her own situation the conflict in which she feels 
entangled and the way to protect herself from the unwanted consequences 
of her sexual life. She will simply deny any value to the life which has 
started in her body, against her lifestyle choice, or she will despise it. 
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Conclusion 
This study of the connections between oral contraception and 
voluntary abortion suggests the following remarks: 
1) In the quest for an " ideal contraceptive", more effective but with fewer 
side effects and less risk of complication, pharmacological research renders 
contraception more and more abortifacient. This does not seem to concern 
public opinion so much, ever since it was decreed that the early embryo 
was not an embryo. What would have been a major obstacle to 
contraception at the time of the encyclical Humanae Vitae is now accepted 
without resistance. This is either through ignorance or voluntary, self-
inflicted blindness coming from the contraceptive mentality. Finally, the 
distinction between contraception and abortion becomes more blurred 
every day. It even disappears with the "menstrual regulation method"So, 
using mijepris/one, the famous abortive pill RU_486s1 , promoted by Pro 
Etienne-Emile Baulieu.s2 The same drug, RU-486, can be used either as a 
"contraceptive" or "contragestative" to induce an early abortion. 
2) Oral contraception, far from being, as its promoters claimed, "the most 
effective remedy against abortion" (Evangelium Vitae 13) finds today 
abortion as its ultimate development. This, after contraception has failed. 
It is misleading to promote contraception as an antidote to abortion; it is 
slanderous to accuse those who oppose contraception as promoting 
abortion. The fact is, contraception and abortion are interconnected, "fruits 
of the same tree." 
3) The root of the problem seems to lie in the contraceptive mentality, 
which seeks to exclude the procreative aspect of sexual acts and to remove 
all responsibility for the procreative consequences when they do occur. 
This bears the hallmark of behavioral characteristics of modem liberal 
society: a "self-centered concept of freedom" (EVI3) , a denial of truth. 
4) The solution to the problem of responsible parenthood does not lie in the 
spread of contraception. The Church asks parents to procreate in a 
responsible, reasonable way for the sake of their children. Periodic 
continence and other natural methods, seem to be the real answer. Using 
periodic continence, parents do not deny the reality of sexual acts and do 
not reject their procreative dimension . They simply abstain from carrying 
out the acts which may lead to procreation. The embryo is still respected 
for what it is - a human being - and parents assume their responsibility in 
accepting the child when it comes. There is no room for abortion. We can 
May, 2000 71 
add that these so-called "natural methods" have been used for years now, 
and that their scientific efficacy is well recognized.83 
Thirty years after the publication of Humanae Vitae the prophetic 
character of this document appears more and more obvious. At that time, 
Pope Paul VI did not have the data which are now at our disposal. He 
could not know for certain that the spread of the pill would not bring about 
the expected decrease in abortions. He could not know for certain that this 
would create havoc in new families , exaggerate the tendency of people 
toward self-centered attitudes and self-blindness, and would bring the 
disastrous consequences which we know today. 
Despite this lack of certain knowledge, the Pope stood firm in his 
condemnation of the pill. However, his attitude was not one of blind 
intransigence. It is because Pope Paul VI fully understood the far-reaching 
consequences of the voluntary dissociation of the union between 
procreation and sexual acts that he could stand fast. The last thirty years of 
unabated contraception have drained the resources of international 
institutions, without bringing the peace, joy, and harmony predicted by 
Margaret Sanger. The Pope was right when he considered "the pill" not as 
a gift from science but as Pandora' s box. 
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